Serving hundreds of leading biopharmaceutical companies globally:

Generated: February 19, 2019

DrugPatentWatch Database Preview

JETREA Drug Profile

« Back to Dashboard

Summary for Tradename: JETREA

Patents:	8
Applicants:	1
BLAs:	1
Suppliers: see list	1

Pharmacology for JETREA

Ingredient-type	Peptide Hydrolases

US Patents for JETREA

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source
Thrombogenics, Inc	JETREA	ocriplasmin	INJECTABLE; INTRAVITREAL	125422	001	2012-10-17	➤ Sign Up	Thromb-X nv (Leuven, BE)	➤ Sign Up	RX		company
Thrombogenics, Inc	JETREA	ocriplasmin	INJECTABLE; INTRAVITREAL	125422	001	2012-10-17	➤ Sign Up	ThromboGenics NV (Leuven, BE)	➤ Sign Up	RX		company
Thrombogenics, Inc	JETREA	ocriplasmin	INJECTABLE; INTRAVITREAL	125422	001	2012-10-17	➤ Sign Up	ThromboGenics NV (Heverlee, BE)	➤ Sign Up	RX		company
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Patent Expiration	Status	Orphan	Source

International Patents for JETREA

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Country	Document Number	Estimated Expiration
Hong Kong	1082419	➤ Sign Up
Canada	2508606	➤ Sign Up
Luxembourg	92273	➤ Sign Up
Country	Document Number	Estimated Expiration

Supplementary Protection Certificates for JETREA

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1390041-0	Sweden	➤ Sign Up	PRODUCT NAME: MIKROPLASMIN; REG. NO/DATE: EU/1/13/819/001 20130313
13C0052	France	➤ Sign Up	PRODUCT NAME: MICROPLASMINE; REGISTRATION NO/DATE: EU/1/13/819/001 20130313
PA2013020,C1581254	Lithuania	➤ Sign Up	PRODUCT NAME: OCRIPLASMINUM (MICROPLASMINUM); REGISTRATION NO/DATE: EU/1/13/819/001 20130313
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald

Healthtrust

Deloitte

Express Scripts

Julphar

Merck

Argus Health

Moodys

AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.